IMMU

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Immunomedics, Inc.

[Business Wire] – Robbins Geller Rudman & Dowd LLP today announced that a class action has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click […]

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Immunomedics, Inc.

[Business Wire] – Robbins Geller Rudman & Dowd LLP today announced that a class action has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click […]

11:14 am Immunomedics announces issuance of U.S. Patent which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration

moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

Immunomedics Extends Patent Life on Therapeutic Antibodies

[GlobeNewswire] – MORRIS PLAINS, N.J. — Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

Immunomedics to Present at Cowen and Company 34th Annual Health Care Conference

[GlobeNewswire] – MORRIS PLAINS, N.J. — Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

Immunomedics seen holding up

moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

IMMUNOMEDICS INC Financials

moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

Immunomedics’ CEO Discusses F2Q 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Cynthia Sullivan – President and Chief Executive Officer Thank you, Peter and good morning everyone. This morning I would like to align my comments to the priorities communicated within our new corporate … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click […]

IMMUNOMEDICS ANNOUNCES CLIVATUZUMAB-BASED BLOOD TEST CAN DIFFERENTIATE BETWEEN PANCREATIC CANCER AND CHRONIC PANCREATITIS

[at noodls] – IMMUNOMEDICS,® INC. … This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

IMMUNOMEDICS TO PRESENT AT COWEN AND COMPANY 33RD ANNUAL HEALTH CARE CONFERENCE

[at noodls] – IMMUNOMEDICS,® INC….This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]